- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
Lotus Pharmaceutical
Market Cap: NT$76.4b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$290.50
7D
-5.2%
1Y
14.4%
PharmaEngine
Market Cap: NT$9.8b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$68.00
7D
-0.9%
1Y
-32.3%
TTY Biopharm
Market Cap: NT$19.8b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$79.70
7D
-2.3%
1Y
8.4%